Tri Chemical Q1 Net Profit Jumps 54% to ¥1.9 Billion on Semiconductor-Materials Demand; FY27 Guidance Stays Cautious

First-quarter revenue rose 14.0% to ¥7.49 billion and operating profit climbed 20.8% to ¥2.07 billion as demand for high-purity precursor materials used in advanced semiconductor manufacturing stayed strong. Ordinary profit surged 51.5% and net profit attributable to owners jumped 53.6% to ¥1.86 billion (EPS ¥57.09), lifted by non-operating gains — yet management left full-year guidance unchanged, implying softer profit over the balance of the year against a high prior-year base.

Silicon wafer representing semiconductor precursor materials Tri Chemical Laboratories Inc. · Tokyo Stock Exchange Prime

Tri Chemical Laboratories Inc. (TSE: 4369) reported consolidated results for the first quarter of the fiscal year ending January 31, 2027 (the three months from February 1 to April 30, 2026) under Japanese GAAP. Revenue rose 14.0% to ¥7,488 million, operating profit increased 20.8% to ¥2,069 million, ordinary profit jumped 51.5% to ¥2,485 million, and net profit attributable to owners of the parent advanced 53.6% to ¥1,855 million. Basic earnings per share were ¥57.09, up from ¥37.16 a year earlier, and comprehensive income more than doubled (+101.7%) to ¥1,749 million.

Advanced-node and AI demand underpins the precursor business

Tri Chemical develops and manufactures high-purity chemical materials — precursors and specialty gases used in chemical-vapor-deposition (CVD) and atomic-layer-deposition (ALD) thin-film processes at the heart of leading-edge logic and memory production. The continued build-out of advanced-node and AI-related semiconductor capacity has kept order volumes firm, supporting the double-digit top-line growth. The gap between ordinary profit (+51.5%) and operating profit (+20.8%) reflects non-operating items, including foreign-exchange gains on the company's overseas-denominated balances.

Balance sheet stays conservative; equity ratio 77.9%

Total assets stood at ¥47,174 million, broadly flat against ¥47,274 million at the prior fiscal year-end, while net assets rose to ¥36,761 million. The equity ratio firmed to 77.9% from 76.5%, leaving Tri Chemical with a debt-light position to fund capacity expansion. The company maintained its dividend plan, guiding a full-year payout of ¥35.00 per share, unchanged from the prior year.

Full-year guidance held — implying a softer H2

Despite the strong start, Tri Chemical left its FY1/2027 forecast intact: full-year revenue of ¥27,000 million (+13.1%), operating profit of ¥6,000 million (+1.7%), ordinary profit of ¥6,300 million (−11.1%) and net profit of ¥4,600 million (−16.6%), for EPS of ¥141.55. The first-half plan (revenue ¥13,700 million, net profit ¥2,190 million) already embeds a year-on-year profit decline, signalling that the FY26 base — inflated by sizeable foreign-exchange and non-operating gains — is unlikely to repeat. With Q1 net profit already at roughly 40% of the full-year target, the guidance leaves room for upside should demand and the yen cooperate.

Tri Chemical Laboratories — Q1 FY1/2027 Key Financials (J-GAAP, consolidated)
MetricQ1 FY1/2027Q1 FY1/2026YoY
Revenue (¥ billion)7.496.57+14.0%
Operating profit (¥ billion)2.071.71+20.8%
Ordinary profit (¥ billion)2.491.64+51.5%
Net profit attrib. to owners (¥ billion)1.861.21+53.6%
EPS (¥)57.0937.16+53.6%
Equity ratio77.9%76.5%+1.4pp
FY27 revenue guidance (¥ billion)27.0+13.1%
FY27 net profit guidance (¥ billion)4.6-16.6%

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.